Correlation Between Rigel Pharmaceuticals and Telix Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Rigel Pharmaceuticals and Telix Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rigel Pharmaceuticals and Telix Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rigel Pharmaceuticals and Telix Pharmaceuticals Limited, you can compare the effects of market volatilities on Rigel Pharmaceuticals and Telix Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rigel Pharmaceuticals with a short position of Telix Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rigel Pharmaceuticals and Telix Pharmaceuticals.

Diversification Opportunities for Rigel Pharmaceuticals and Telix Pharmaceuticals

0.61
  Correlation Coefficient

Poor diversification

The 3 months correlation between Rigel and Telix is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Rigel Pharmaceuticals and Telix Pharmaceuticals Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Telix Pharmaceuticals and Rigel Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rigel Pharmaceuticals are associated (or correlated) with Telix Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Telix Pharmaceuticals has no effect on the direction of Rigel Pharmaceuticals i.e., Rigel Pharmaceuticals and Telix Pharmaceuticals go up and down completely randomly.

Pair Corralation between Rigel Pharmaceuticals and Telix Pharmaceuticals

Given the investment horizon of 90 days Rigel Pharmaceuticals is expected to generate 4.0 times more return on investment than Telix Pharmaceuticals. However, Rigel Pharmaceuticals is 4.0 times more volatile than Telix Pharmaceuticals Limited. It trades about 0.37 of its potential returns per unit of risk. Telix Pharmaceuticals Limited is currently generating about 0.14 per unit of risk. If you would invest  1,407  in Rigel Pharmaceuticals on September 3, 2024 and sell it today you would earn a total of  1,354  from holding Rigel Pharmaceuticals or generate 96.23% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Rigel Pharmaceuticals  vs.  Telix Pharmaceuticals Limited

 Performance 
       Timeline  
Rigel Pharmaceuticals 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Rigel Pharmaceuticals are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite quite unfluctuating technical and fundamental indicators, Rigel Pharmaceuticals disclosed solid returns over the last few months and may actually be approaching a breakup point.
Telix Pharmaceuticals 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Telix Pharmaceuticals Limited are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Telix Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

Rigel Pharmaceuticals and Telix Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Rigel Pharmaceuticals and Telix Pharmaceuticals

The main advantage of trading using opposite Rigel Pharmaceuticals and Telix Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rigel Pharmaceuticals position performs unexpectedly, Telix Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telix Pharmaceuticals will offset losses from the drop in Telix Pharmaceuticals' long position.
The idea behind Rigel Pharmaceuticals and Telix Pharmaceuticals Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk